Ketamine for PTSD: Well, Isn’t That Special

Dr. Stein has received research grant support from the Department of Defense, the Department of Veterans Affairs, and NIH; he has received consulting fees from Acadia Pharmaceuticals, Actelion, Aptinyx, Bionomics, BioXcel Therapeutics, Clexio, EmpowerPharm, GW Pharmaceuticals, Janssen, Jazz Pharmaceuticals, and Roche/Genentech; he has stock options in Epivario and Oxeia Biopharmaceuticals; and he receives royalties and editorial stipends from Wiley (Anxiety and Depression), Elsevier (Biological Psychiatry), and Wolters Kluwer (UpToDate). Dr. Simon has received research grant support from the American Foundation for Suicide Prevention, the Department of Defense, the Highland Street Foundation, NIH, and PCORI; she has received salary support from Cohen Veterans Network, consulting fees from Aptinyx, Axovant Sciences, BehavR LLC, Genomind, the Massachusetts General Hospital Psychiatry Academy, Praxis Therapeutics, SpringWorks, Vanda Pharmaceuticals, and Wiley; she has received royalties from American Psychiatric Association Publishing and Wolters Kluwer; and she has spousal equity in G1 Therapeutics and Zentalis.